Trial Profile
Safety of the Etonogestrel-releasing Implant During the Puerperium of Healthy Women
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Etonogestrel (Primary) ; Medroxyprogesterone
- Indications Pregnancy
- Focus Pharmacodynamics
- 22 May 2010 Results (effects on haemostatic system) reported at 11th Congress of the European Society of Contraception.
- 01 Dec 2009 Results published in Contraception.
- 09 Oct 2009 Pharmacodynamic results, with respect to metabolic parameters, presented at the 19th FIGO World Congress of Gynecology and Obstetrics.